Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I only have myself to blame for continuing my unhealthy shareholding in Hemo. I have been here since pre covid and the same old same old happens constantly. I thought now we had crossed in to clinical we would have been able to raise higher. I thought at the time of the last 2 RNSs that was what Vlad/Hemo were trying to achieve to push up the price and raise at about 3+. Mint, constant smoke and mirror tweeting, my telling myself he’s a good Scientist not businessman, the battle between rampers and derampers (derampers seem to be proven right more often) rinse and repeat. Hope one day the record changes.
Haywan/Mr India OCTP got through a phase 1 trial and the share price fell back considerably. Don’t know if that is comparable to Hemo on value of treatment product/market as there's was for Canaboid based Neurological pain relief. I believe it was the funding question why they fell which is still being resolved.
Am not sure if already stated but would phase 1 trials of the drug be to check safety in humans eg side effects before then moving to see if effective in phase 2 and then a wider viability study in phase 3. Sorry if I have completely misunderstood.
There are some names on here I haven't seen before which does seem to happen with a Pump and Dump however there is a genuine reason for the share price to rise based on anticipation of FDA result in my lowly opinion.
JHFH. I agree with that just burned camp feeling. I was frustrated by Mint and the delay with Phase 1. Hope they have been learning for all on the Hemo board. We will see. Moving on seems to be some interest today. Dhub will have undoubtedly noted that it is negotiated to buy on Halifax.